Status:
RECRUITING
Post-Trial Tuberculosis Case Finding: A Substudy of CoVPN 3008
Lead Sponsor:
COVID-19 Prevention Network
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Medical Research Council, South Africa
Conditions:
Tuberculosis
Eligibility:
All Genders
18+ years
Brief Summary
This substudy aims to identify cases of tuberculosis after the CoVPN 3008 clinical trial is completed.
Detailed Description
This observational substudy will involve participants from the CoVPN 3008 trial, regardless of their HIV status, to study tuberculosis (TB). At the start, all participants will be screened for TB, eve...
Eligibility Criteria
Inclusion
- Enrollment into the CoVPN 3008 clinical trial.
- Able and willing to complete the informed consent process: Volunteer demonstrates an understanding of this substudy.
- Willingness to discuss TB status, undergo related testing/monitoring labs, and receive referrals for TB care.
Exclusion
- Investigator's concern for difficulty with venous access based on clinical history and physical examination.
Key Trial Info
Start Date :
October 21 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 5 2025
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT06585683
Start Date
October 21 2024
End Date
October 5 2025
Last Update
February 11 2025
Active Locations (41)
Enter a location and click search to find clinical trials sorted by distance.
1
Gaborone CRS
Gaborone, Botswana
2
Eswatini Prevention Center CRS
Mbabane, Eswatini
3
Moi University Clinical Research Centre
Eldoret, Kenya
4
Kisumu Crs
Kisumu, Kenya